Proven leaders in biologics manufacturing are aligning their strengths to deliver a more efficient and cost-optimized drug development supply chain, worldwide Alliance aims to expedite time to market ...

Incremental bioprocess improvements may be realized now through contiGuous bioprocessing, a next-generation approach to continuous bioprocessing enabled by MilliporeSigma’s BioContinuum™ Platform.

Reinforces company’s commitment to differentiated solutions that enable faster and more effective drug development HUB’s organoid offering complements company’s cell culture portfolio of media, ...

Young and emerging biotechnology companies rarely have enough background in biomanufacturing operations and clinical experience to get their products to the markets in an economic and efficient manner ...